STAT+: John Maraganore on what comes next for Alnylam and his career
John Maraganore, the longtime CEO of Alnylam Pharmaceuticals, is stepping down after almost 20 years at the company. Maraganore spoke with our "Readout LOUD" hosts this week about his decision.
This interview is an excerpt from a recent segment on “The Readout LOUD.” Listen to the full episode here.
John Maraganore, the longtime CEO of Alnylam Pharmaceuticals, is stepping down after almost 20 years at the company. Maraganore spoke with “The Readout LOUD” this week about his decision.
This interview has been condensed and edited for clarity.
So tell us about your decision to leave. Why now?
Well, you know, after 19 amazing years of building Alnylam and bringing RNAi Therapeutics to patients around the world, I decided that this is the right time to start a new chapter. I’m excited about doing things in the industry and in a different way. And that’s why I made the
